References
- Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995; 131: 1453–7.
- Prignano F, Ortonne JP, Buggiani G, Lotti T. Therapeutic approaches in melasma. Dermatol Clin. 2007; 25: 337–42.
- Keeling J, Cardona L, Benitez A, Epstein R, Rendon M. Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. Cutis. 2008; 81: 179–83.
- Grimes PE. An efficacy study of three commercially available hydroquinone 4% treatments for melasma. Cutis. 2007; 80: 497–
- Khunger N, Sarkar R, Jain R. Tretinoin peels versus glycolic acid peels in the treatment of melasma in dark skinned patients. Dermatol Surg. 2004; 30: 756–60.
- Lawrence N, Cox SE, Brody HJ. Treatment of melasma with Jessners solution verus glycolic acid: a comparison of clinical efficacy and evaluation of the predicive ability of Wood’s light examination. J Am Acad Dermtol. 1997; 36: 589–93.
- Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006; 55: 1048–65.
- Rusciani R, Motta A, Rusciani L, Alfano C. Q‐switched alexandrite laser‐assisted treatment of melasma: 2‐year follow‐up monitoring. J Drugs Dermatol. 2005; 4: 770–9.
- Kimbrough‐Green CK, Griffiths CM, Finkel LJ, Hamilton TA, Bulengo‐Ranshy SM, Ellis CN, Voorhees JJ. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol. 1994; 130: 727–
- Hexsel D, Arellano I, Rendon M. Ethnic considerations in the treatment of Hispanic and Latin‐American patients with hyperpigmentation. Br J Dermatol. 2007; 156: 7–12.
- Sanchez J, Vazquez M. A hydroquinone solution in the treatment of melasma. Int J Dermatol. 1982; 21: 55–58.
- Glenn M, Grimes PE, Pitt E, Chalet M, Kelly AP. Evaluation of clinical and light microscopic effects of various concentrations of hydroquinone. Clin Res. 1991; 39: 83A–
- Tsai T, Bowman P, Jee S, Maibach H. Effects of glycolic acid on light‐induced skin pigmentation in Asian and Caucasian subjects. J Am Acad Dermatol. 2000; 43: 238–43.
- Lee GY, Kim HJ, Whang KK. The effects of combination treatment of recalcitrant pigmentary disorders with pigmented laser and chemical peeling. Dermatol Surg. 2002; 28: 1120–3.
- Karasi S, Raulin C. Fractional photothermolysis: a new option for treating melasma?. Hautartzt. 2008; 59: 92–100.
- Kilmer SL, Wheeland RG, Goldberg DJ, Andveson R. Treatment of epidermal pigmented lesions with the frequency doubled Q‐switched Nd:YAG laser. A controlled, single-impact, response, multicenter trial. Arch Dermatol. 1994; 130: 1515–19.
- Taylor CR, Anderson RR. Ineffective treatment of melasma and post inflammatory hyperpigmentation by Q‐switched ruby laser. J Dermatol Surg Oncol. 1994; 20: 592–7.